Anti-PTEN antibody-conjugated liposomes have shown significant potential in ovarian cancer research. By targeting cells with PTEN expression deficiency, these liposomes can effectively enhance the selectivity and targeting of drugs. Studies indicate that anti-PTEN antibody-conjugated liposomes demonstrate significant improvements in drug delivery and therapeutic effects compared to traditional methods. This strategy may provide new treatment options for ovarian cancer patients and promote the development of personalized medicine.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1640z | Mouse Anti-PTEN Recombinant Antibody (clone 27C11) | WB, ELISA, FC, ICC, IF | Mouse IgG1 |
MOB-0338MZ | Recombinant Mouse Anti-Human PTEN Antibody (clone 7I3.2) | IHC | Mouse antibody |
MRO-1293-CN | Recombinant Rabbit Anti-PTEN Monoclonal Antibody (CBACN-466) | WB, IF, IHC | Rabbit IgG |
ZG-0527U | Rabbit Anti-Phospho-PTEN (S380) Recombinant Antibody (clone 4D10) | ELISA, WB | Rabbit IgG |
VS3-XY1314 | Mouse Anti-PTEN Recombinant Antibody (clone 4D8) | WB, IP, IF | Mouse IgG1 |
There are currently no Customer reviews or questions for VS-1024-FY219. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.